Correlation analysis of long non-coding RNA TUG1 with disease risk, clinical characteristics, treatment response, and survival profiles of adult Ph− Acute lymphoblastic leukemia

Background: Long non-coding RNA taurine-upregulated gene 1 (lncRNA TUG1) is reported to be involved in the progression and development of several malignancies; however, its role in Philadelphia chromosome-negative acute lymphoblastic leukemia (Ph−ALL) is unknown. The present study aimed to explore t...

Full description

Bibliographic Details
Main Authors:	Cao, T. (Author), Chai, Y. (Author), Chen, H. (Author), Hu, W. (Author), Li, J. (Author), Li, L. (Author), Li, Y. (Author), Liu, H. (Author), Wu, C. (Author), You, C. (Author), Yue, L. (Author), Zeng, P. (Author), Zhang, Y. (Author)
Format:	Article
Language:	English
Published:	John Wiley and Sons Inc 2021
Subjects:	acute lymphoblastic leukemia adult Adult allogeneic hematopoietic stem cell transplantation Article atypical chronic myeloid leukemia Biomarkers, Tumor bone marrow donor cancer epidemiology cancer prognosis cancer survival carcinogenesis case control study Case-Control Studies central nervous system leukemia clinical feature controlled study disease free survival Disease-Free Survival female Female gene expression gene expression regulation Gene Expression Regulation, Neoplastic genetic analysis genetic association genetic predisposition Genetic Predisposition to Disease genetics hematopoietic stem cell transplantation Hematopoietic Stem Cell Transplantation human human cell Humans leukemia remission Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative leukocyte count long non-coding RNA TUG1 long untranslated RNA major clinical study male Male monocyte mortality overall survival patient care Philadelphia chromosome-negative acute lymphoblastic leukemia Precursor Cell Lymphoblastic Leukemia-Lymphoma prognosis Prognosis real time reverse transcription polymerase chain reaction Retrospective Studies retrospective study reverse transcription-quantitative polymerase chain reaction risk factor RNA, Long Noncoding survival treatment outcome Treatment Outcome treatment response TUG1 gene TUG1 long noncoding RNA, human tumor marker upregulation
Online Access:	View Fulltext in Publisher

Internet

View Fulltext in Publisher

Correlation analysis of long non-coding RNA TUG1 with disease risk, clinical characteristics, treatment response, and survival profiles of adult Ph− Acute lymphoblastic leukemia

Internet

Similar Items